Table 2. Studies describing qualitative factors influencing coverage.
Intervention | Study | Study Design | Country | Methods | Integrateda |
---|---|---|---|---|---|
Combined school- and community-based | Fleming 2009 [29] | Observational | Uganda | Key informant interviews and focus group discussions (FGDs) | No |
Kabatereine 2006 [30] | Pre-postb | Uganda | Key informant interviews | No | |
Community-based | Dabo 2013 [31] | Pre-post | Mali | Drug distributor registers, census, household surveys, FGDs, interviews | No |
Omedo 2012 [32] | Observational | Kenya | Unstructured group discussions | No | |
Omedo 2014 [33] | Pre-post | Kenya | Semi-structured group discussions with drug distributers | No | |
School-based | Muhumuza 2014 [34] | Randomized comparative trial | Uganda | Interviews of children | No |
Muhumuza 2015 [35] | Observational | Uganda | Key informant interviews and FGDs | No | |
School- based vs. community-based | Massa 2009c [36] | Observational | Tanzania | In-depth interviews and FGDs | No |
a Programs considered to be “integrated” if they included distribution of drugs other than PZQ and albendazole or mebendazole
b Pre-post indicates outcomes were scored based on pre- and post-intervention surveys of a non-randomized trial to improve participation